abcam named ‘Antibody Supplier of the Year’ by CiteAb
Cambridge, UK — March 27, 2023 — abcam (NASDAQ: ABCM) a global life science company working together with researchers to advance science and enable faster breakthroughs, today announces it has been named ‘Antibody Supplier of the Year’ in CiteAb’s prestigious annual industry awards. This follows abcam’s recent inclusion in Fast Company’s list of the World’s Most Innovative Companies for its pioneering work to improve data reproducibility.
The CiteAb ‘Antibody Supplier of the Year’ award recognizes the supplier with the most citations for antibody products in 2022. abcam also received ‘highly commended’ in the category ‘Post Translational Modification Antibody Supplier of the Year’’, acknowledging the challenge of developing and validating antibodies against these difficult targets.
Dr Alejandra Solache, SVP R&D at abcam and recipient of the 2021 CiteAb award for “Significant Individual Impact” commented: “Being recognized as ‘Antibody Supplier of the Year’ is a huge honor and highlights the confidence the community has in our products. We are very proud to have contributed to scientific discovery on this scale and would like to thank CiteAb and the scientific community for this recognition. The achievement emphasizes the importance of our continuing commitment to deliver consistent, high-quality products which support more reproducible science.”
Dr Andrew Chalmers, CEO and founder of CiteAb, commented: ‘We are delighted to award abcam with the ‘Antibody Supplier of the Year’ Award, and name them as Highly commended in the ‘PTM Antibody Supplier of the Year’ Award. To determine winners in these categories, we delved into our antibody citation database. Their success in these categories is a testament to the hard work of their teams and how successful their antibodies have been in supporting a huge number of researchers carry out their science! Many congratulations to everyone at abcam.’
CiteAb’s annual awards were launched in 2014 to celebrate the work and impact of companies and individuals in the global research reagent sector, recognizing the essential role that reagents play in accelerating scientific progress. The awards look to recognize life sciences providers making a significant impact to the industry in terms of antibody data, validation testing and reproducibility.